"Antibody of Unknown Significance" (AUS): The Issue of Interpreting Antibody Test Results
Mov Disord
.
2021 Jul;36(7):1543-1547.
doi: 10.1002/mds.28597.
Epub 2021 May 6.
Authors
Bettina Balint
1
2
,
Kailash P Bhatia
2
,
Josep Dalmau
3
4
5
6
7
Affiliations
1
Department of Neurology, University Hospital, Heidelberg, Germany.
2
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
3
Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
4
Service of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain.
5
Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
6
Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain.
7
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
PMID:
33955060
DOI:
10.1002/mds.28597
No abstract available
Keywords:
AUS; antibodies; antibody of unknown significance; autoimmune movement disorders.
MeSH terms
Antibodies*
Humans
Retrospective Studies
Substances
Antibodies